Further, clinical and serologic activity was more frequent in patients with SLE with both low C3 and C4 levels, which supports the rationale for a higher weighting of low C3 and C4 levels in the EULAR/ACR classification criteria. The gene discussed is C3; the disease is systemic lupus erythematosus.